Zwitterion-exchange type chiral stationary phases agreement

CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange type chiral stationary phases (CSPs), invented and developed by researchers at the University of Vienna.

Chiral Technologies Europe (CTE) has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange type chiral stationary phases (CSPs), invented and developed by researchers at the University of Vienna. The company claims that the addition of the new CSPs will provides a significant expansion of its portfolio of enantioselective chromatography products.

“The opportunity to collaborate with Professor Lindner and his renowned research team at the University of Vienna on the commercialization of this new stationary phase fits nicely within our broader strategy to expand our position in supplying new chirality tools to the life science industry,” said Dieter Heckmann, president and CEO of CTE.

The zwitterion-exchange type CSPs are reported to separate a broad range of ionizable chiral analytes, ranging from acidic and basic molecules to zwitterionic molecules that bear basic and acidic moieties in the same molecule. The company claims that it has also been adapted for direct enantiomer resolution of natural and synthetic free a-, b-, g-amino acids without requiring pre-column derivatization. In addition, chiral zwitterionic peptides and peptomimetics can be separated into their respective stereoisomers. The new selectors can be used in liquid chromatography and supercritical fluid chromatography modes with mobile phases that are compatible with all LC–MS applications.

For more information visit www.chiraltech.com